A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of Migraine
Clinical trial NCT00821483 · COMPLETED
Trial details
- NCT number
- NCT00821483
- Sponsor
- SK Chemicals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2008-02-01
- Enrollment
- 298
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.